Cel-Sci
CVM
#9907
Rank
โ‚น3.54 B
Marketcap
โ‚น443.16
Share price
-10.73%
Change (1 day)
-77.50%
Change (1 year)

EPS for Cel-Sci (CVM)

EPS in 2025 (TTM): -โ‚น953.27

According to Cel-Sci 's latest financial reports the company's current EPS (TTM) is -โ‚น1,014. In 2024 the company made an earnings per share (EPS) of -โ‚น46.03 an increase over its 2023 EPS that were of -โ‚น65.89.

EPS history for Cel-Sci from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น953.271970.95%
2024-โ‚น46.03-30.14%
2023-โ‚น65.89-16.09%
2022-โ‚น78.52-3.33%
2021-โ‚น81.239.76%
2020-โ‚น74.0115.49%
2019-โ‚น64.08-62.03%
2018-โ‚น168.782.19%
2017-โ‚น165.17-22.78%
2016-โ‚น213.91-77.45%
2015-โ‚น948.59-13.14%
2014-โ‚น1,09261.33%
2013-โ‚น676.92-57.14%
2012-โ‚น1,579-45.31%
2011-โ‚น2,888-420%
2010โ‚น902.56-112.9%
2009-โ‚น6,995342.86%
2008-โ‚น1,579-30%
2007-โ‚น2,256-0%
2006-โ‚น2,256150%
2005-โ‚น902.56-0%
2004-โ‚น902.56-75%
2003-โ‚น3,610-54.29%
2002-โ‚น7,897-31.37%
2001-โ‚น11,50815.91%
2000-โ‚น9,928-15.38%
1999-โ‚น11,733-29.73%
1998-โ‚น16,697-26%
1997-โ‚น22,564-13.79%
1996-โ‚น26,174

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Curis
CRIS
-โ‚น331.24-67.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น4.51-99.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,176-215.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น159.75-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น56.86-105.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚น942.22-192.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น127.26-112.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น6,924 582.47%๐Ÿ‡บ๐Ÿ‡ธ USA